ICH M7

An international guideline providing a framework for the assessment and control of DNA-reactive (mutagenic) impurities in pharmaceuticals, to limit potential carcinogenic risk.

ICH M7 is the reference framework used when assessing nitrosamine and other mutagenic-impurity risk after a manufacturing or formulation change.